Company Filing History:
Years Active: 2024
Title: Scott G Filler: Innovator in Macrophage Therapeutics
Introduction
Scott G Filler is a notable inventor based in San Pedro, California. He has made significant contributions to the field of biomedical innovation, particularly in the area of macrophage therapeutics. His work focuses on the priming of macrophage cells for therapeutic applications.
Latest Patents
Scott G Filler holds a patent titled "Target-primed macrophages and therapeutic uses thereof." This patent describes cell populations, compositions, and methods related to the target priming of macrophage cells. The macrophages, once primed or activated with a microorganism, can be utilized to prevent or treat infections caused by that microorganism. Additionally, when primed or activated by tumor cells or tumor antigens, these macrophage cells can be employed to prevent or treat tumors of the same kind. The priming process can be conducted in vitro or ex vivo, and the macrophages can be isolated from the subject undergoing disease prevention or treatment.
Career Highlights
Scott G Filler is affiliated with The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. His work at this institution has allowed him to explore innovative approaches to disease treatment and prevention.
Collaborations
Some of his notable coworkers include Liana Chan and Michael R Yeaman, who contribute to the collaborative efforts in research and development within the institute.
Conclusion
Scott G Filler's innovative work in macrophage therapeutics represents a significant advancement in biomedical research. His contributions have the potential to impact the treatment of infections and tumors, showcasing the importance of targeted therapies in modern medicine.